Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Lumos Pharma (LUMO) has a market cap of $37.535 million USD. According to our data, Lumos Pharma is ranked No.8315 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Dec 13, 2024 | $37.54 M |
36.48%
|
| Dec 29, 2023 | $27.50 M |
-11.91%
|
| Dec 30, 2022 | $31.22 M |
-47.91%
|
| Dec 31, 2021 | $59.93 M |
-80.59%
|
| Dec 31, 2020 | $0.31 B |
56.83%
|
| Dec 31, 2019 | $0.20 B |
66.45%
|
| Dec 31, 2018 | $0.12 B |
-81.26%
|
| Dec 29, 2017 | $0.63 B |
-21.11%
|
| Dec 30, 2016 | $0.80 B |
-71.75%
|
| Dec 31, 2015 | $2.83 B |
-8.45%
|
| Dec 31, 2014 | $3.09 B |
80.60%
|
| Dec 31, 2013 | $1.71 B |
76.08%
|
| Dec 31, 2012 | $0.97 B |
77.56%
|
| Dec 30, 2011 | $0.55 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Ascendis Pharma
ASND
|
$7.53 B |
0.000 M
|
Denmark
|
 Crinetics Pharmaceuticals
CRNX
|
$3.58 B |
0.000 M
|
USA
|
 OPKO Health
OPK
|
$0.99 B |
-0.000 M
|
USA
|
 TherapeuticsMD
TXMD
|
$11.99 M |
0.000 M
|
USA
|
 Soleno Therapeutics
SLNO
|
$2.09 B |
0.000 M
|
USA
|
 Xeris Pharmaceuticals
XERS
|
$0.49 B |
-0.000 M
|
USA
|
 Aeterna Zentaris
AEZS
|
$17.51 M |
6.099 M
|
USA
|
 Ultragenyx
RARE
|
$3.97 B |
0.000 M
|
USA
|
| Market Cap | = | LUMO Stock Price | * | LUMO Shares Outstanding |
| = | $4.34 | * | 8.65 M | |
| = | $37.54 M |